68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.

CONCLUSIONS: The sequential imaging approach designed to limit Ga-PSMA imaging to patients with negative choline scans resulted in high detection rates. Ga-PSMA-PET/CT identified sites of recurrent disease in 43.8% of the patients with negative F-choline PET/CT scans. PMID: 26975008 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26975008?dopt=Abstract

Source: Clinical Prostate Cancer - March 11, 2016 Category: Cancer & Oncology Authors: Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K Tags: Clin Nucl Med Source Type: research